SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-22-000023
Filing Date
2022-05-05
Accepted
2022-05-05 16:26:26
Documents
62
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q prta-20220331.htm   iXBRL 10-Q 1337731
2 EX-31.1 prta2022q110-qxex311.htm EX-31.1 11174
3 EX-31.2 prta2022q110-qxex312.htm EX-31.2 11287
4 EX-32.1 prta2022q110-qxex321.htm EX-32.1 8923
  Complete submission text file 0001559053-22-000023.txt   5915904

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20220331.xsd EX-101.SCH 52594
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20220331_cal.xml EX-101.CAL 72525
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20220331_def.xml EX-101.DEF 223768
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20220331_lab.xml EX-101.LAB 569047
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20220331_pre.xml EX-101.PRE 367867
56 EXTRACTED XBRL INSTANCE DOCUMENT prta-20220331_htm.xml XML 730702
Mailing Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60
Business Address 77 SIR JOHN ROGERSON'S QUAY, BLOCK C GRAND CANAL DOCKLANDS DUBLIN 2 L2 D02 VK60 011-353-1-236-2500
PROTHENA CORP PUBLIC LTD CO (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 22896763
SIC: 2834 Pharmaceutical Preparations